The potential of the company I feel has grown since the webinar as I never factored in TMVR, more shaped products, other tissue products in the 12b dollar market and our TAVR product really looks the goods. We just need to see exponential growth of the Adapt products to confirm my belief.
Anyone out there who is looking for a good investment book should read 100 baggers. All the things they look for when trying to find a 100 bagger applies to Admedus and the book has taught me to hold exceptional companies for the long term.
Ann: Investor Webinar Presentation, page-86
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
-0.240(1.29%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.15 | $18.20 | $159.7K | 8.611K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.33 | 90 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |